O. Olsen and P. Gøtzsche, Screening for breast cancer with mammography, Cochrane Database Syst Rev, issue.4, p.1877, 2001.
DOI : 10.1002/14651858.CD001877

J. Otten, N. Karssemeijer, J. Hendriks, J. Groenewoud, J. Fracheboud et al., Effect of Recall Rate on Earlier Screen Detection of Breast Cancers Based on the Dutch Performance Indicators, JNCI Journal of the National Cancer Institute, vol.97, issue.10, pp.748-54, 2005.
DOI : 10.1093/jnci/dji131

D. Berry, K. Cronin, S. Plevritis, D. Fryback, L. Clarke et al., Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer, New England Journal of Medicine, vol.353, issue.17, pp.1784-92, 2005.
DOI : 10.1056/NEJMoa050518

M. Bollet, A. Savignoni, J. Pierga, M. Lae, V. Fourchotte et al., High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies, British Journal of Cancer, vol.18, issue.4, pp.734-775, 2008.
DOI : 10.1007/s10549-006-9397-3

H. Bloom and W. Richardson, Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years, Br J Cancer, 1957.

C. Elston and I. Ellis, pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.9, issue.5, pp.154-61, 2002.
DOI : 10.1016/0277-5379(88)90171-X

L. Pusztai, Anatomy and Biology: Two Complementary Sides of Breast Cancer Prognostication, Journal of Clinical Oncology, vol.29, issue.33, pp.4347-4355, 2011.
DOI : 10.1200/JCO.2011.38.2754

R. Blamey, I. Ellis, S. Pinder, A. Lee, R. Macmillan et al., Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990???1999, European Journal of Cancer, vol.43, issue.10, pp.1548-55, 1990.
DOI : 10.1016/j.ejca.2007.01.016

A. Urruticoechea, I. Smith, and M. Dowsett, Proliferation Marker Ki-67 in Early Breast Cancer, Journal of Clinical Oncology, vol.23, issue.28, pp.7212-7232, 2005.
DOI : 10.1200/JCO.2005.07.501

A. Goldhirsch, W. Wood, A. Coates, R. Gelber, B. Thürlimann et al., Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer

S. Lanitis, G. Filippakis, V. Sidhu, A. Mufti, R. Lee et al., Atypical Anaphylactic Reaction to Patent Blue During Sentinel Lymph Node Biopsy for Breast Cancer, The Annals of The Royal College of Surgeons of England, vol.90, issue.4
DOI : 10.1308/003588408X285702

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647203

G. Houvenaeghel, C. Nos, S. Giard, H. Mignotte, B. Esterni et al., A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis, European Journal of Surgical Oncology (EJSO), vol.35, issue.7, pp.690-695, 2009.
DOI : 10.1016/j.ejso.2008.10.003

URL : https://hal.archives-ouvertes.fr/hal-00350099

G. Bonadonna, E. Brusamolino, P. Valagussa, A. Rossi, L. Brugnatelli et al., Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer, New England Journal of Medicine, vol.294, issue.8, pp.405-415, 1976.
DOI : 10.1056/NEJM197602192940801

H. Roché, P. Fumoleau, M. Spielmann, J. Canon, T. Delozier et al., Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial, Journal of Clinical Oncology, vol.24, issue.36, pp.5664-71, 2006.
DOI : 10.1200/JCO.2006.07.3916

H. Bear, S. Anderson, R. Smith, C. Geyer, E. Mamounas et al., Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27, Journal of Clinical Oncology, vol.24, issue.13, pp.2019-2046, 2006.
DOI : 10.1200/JCO.2005.04.1665

E. Mamounas, J. Bryant, B. Lembersky, L. Fehrenbacher, S. Sedlacek et al., Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for nodepositive breast cancer: results from NSABP B-28, J Clin Oncol Off J Am Soc Clin Oncol, 2005.
DOI : 10.1200/jco.2005.10.517

S. Jones, M. Savin, F. Holmes, O. Shaughnessy, J. Blum et al., Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer, Journal of Clinical Oncology, vol.24, issue.34, pp.5381-5388, 2006.
DOI : 10.1200/JCO.2006.06.5391

F. Adjuvant and S. Group, Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5- year follow-up results of French Adjuvant Study Group 05 randomized trial, J Clin Oncol Off J Am Soc Clin Oncol Feb, vol.119, issue.3, pp.602-613, 2001.

D. Slamon, W. Eiermann, N. Robert, T. Pienkowski, M. Martin et al., Adjuvant Trastuzumab in HER2-Positive Breast Cancer, New England Journal of Medicine, vol.365, issue.14, pp.1273-83, 2011.
DOI : 10.1056/NEJMoa0910383

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268553

S. Jones, R. Collea, D. Paul, S. Sedlacek, A. Favret et al., Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study, The Lancet Oncology, vol.14, issue.11, 2013.
DOI : 10.1016/S1470-2045(13)70384-X

A. Jones, M. Barlow, P. Barrett-lee, P. Canney, I. Gilmour et al., Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring, British Journal of Cancer, vol.91, issue.5, pp.684-92, 2009.
DOI : 10.1056/NEJM200001203420301

J. Mackey, M. Clemons, M. Côté, D. Delgado, S. Dent et al., Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group, Current Oncology, vol.15, issue.1, pp.24-35, 2008.
DOI : 10.3747/co.2008.199

C. Early-breast, . Trialists-'collaborative, . Group, . Ebctcg-), C. Davies et al., Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, Lancet Lond Engl, vol.378, issue.9793, pp.771-84, 2011.

C. Early-breast and . Trialists, Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet Lond Engl, vol.365, issue.9472, pp.1687-717, 2005.

A. Howell, Adjuvant aromatase inhibitors for breast cancer, The Lancet, vol.366, issue.9484, 2005.
DOI : 10.1016/S0140-6736(05)67036-5

A. Coates, A. Keshaviah, B. Thürlimann, H. Mouridsen, L. Mauriac et al., Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98, Journal of Clinical Oncology, vol.25, issue.5, pp.486-92, 2007.
DOI : 10.1200/JCO.2006.08.8617

E. Winer, C. Hudis, H. Burstein, A. Wolff, K. Pritchard et al., American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor???Positive Breast Cancer: Status Report 2004, Journal of Clinical Oncology, vol.23, issue.3, pp.619-648, 2004.
DOI : 10.1200/JCO.2005.09.121

S. Goel, R. Sharma, A. Hamilton, and J. Beith, LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women, Cochrane Database Syst Rev, vol.14, issue.34, p.4562, 2009.
DOI : 10.1002/14651858.CD004562.pub4

M. Clarke, R. Collins, S. Darby, C. Davies, P. Elphinstone et al., Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet Lond Engl, vol.366, issue.9503, pp.2087-106, 2005.

M. Clemons, T. Hamilton, and P. Goss, Does treatment at the time of locoregional failure of breast cancer alter prognosis? Cancer Treat Rev, pp.83-97, 2001.

J. Engel, R. Eckel, U. Aydemir, S. Aydemir, J. Kerr et al., Determinants and prognoses of locoregional and distant progression in breast cancer, International Journal of Radiation Oncology*Biology*Physics, vol.55, issue.5, pp.1186-95, 2003.
DOI : 10.1016/S0360-3016(02)04476-0

G. Liljegren, L. Holmberg, J. Bergh, A. Lindgren, L. Tabár et al., 10-Year Results After Sector Resection With or Without Postoperative Radiotherapy for Stage I Breast Cancer: A Randomized Trial, Journal of Clinical Oncology, vol.17, issue.8, pp.2326-2359, 1999.
DOI : 10.1200/JCO.1999.17.8.2326

R. Arriagada, L. Rutqvist, A. Mattsson, A. Kramar, and S. Rotstein, Adequate locoregional treatment for early breast cancer may prevent secondary dissemination., Journal of Clinical Oncology, vol.13, issue.12, pp.2869-78, 1995.
DOI : 10.1200/JCO.1995.13.12.2869

H. Bartelink, P. Maingon, P. Poortmans, C. Weltens, A. Fourquet et al., Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial, The Lancet Oncology, vol.16, issue.1, pp.47-56
DOI : 10.1016/S1470-2045(14)71156-8

P. Romestaing, Y. Lehingue, C. C. Coquard, R. Montbarbon, X. Ardiet et al., Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France., Journal of Clinical Oncology, vol.15, issue.3, 1997.
DOI : 10.1200/JCO.1997.15.3.963

C. Polgár, J. Fodor, Z. Orosz, T. Major, Z. Takácsi-nagy et al., Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial, Strahlenther Onkol Organ Dtsch Röntgenges Al, vol.178, issue.11, pp.615-638, 2002.

H. Bartelink, J. Horiot, P. Poortmans, H. Struikmans, W. Van-den-bogaert et al., Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation, New England Journal of Medicine, vol.345, issue.19, pp.1378-87, 2001.
DOI : 10.1056/NEJMoa010874

H. Bartelink, Systemic adjuvant therapies and radiotherapy to the conserved breast: Strategies revisited, The Breast, vol.16, issue.2, pp.84-92, 2007.
DOI : 10.1016/j.breast.2007.07.010

Y. Belkacémi, A. Fourquet, B. Cutuli, C. Bourgier, M. Hery et al., Radiotherapy for invasive breast cancer: Guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence, Critical Reviews in Oncology/Hematology, vol.79, issue.2, pp.91-102, 2011.
DOI : 10.1016/j.critrevonc.2010.06.002

A. Fourquet, Y. Kirova, M. Bollet, H. Tournat, R. Dendale et al., [Meta-analyses of the effects of radiotherapy in breast cancer: the ultimate evidence?]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.6-7554, 2008.

P. Auberdiac, C. Chargari, L. Cartier, A. Zioueche, A. Mélis et al., Axillary lymph node irradiation in breast cancer: state of the art]. Bull Cancer (Paris), pp.471-478, 2012.

C. Hennequin and A. Fourquet, Controversy about internal mammary chain irradiation in breast cancer]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.5-6351, 2014.

M. Cross, H. Elson, and A. Bs, Breast conservation radiation therapy technique for women with large breasts, International Journal of Radiation Oncology*Biology*Physics, vol.17, issue.1, pp.199-203, 1989.
DOI : 10.1016/0360-3016(89)90389-1

A. Grann, B. Mccormick, E. Chabner, S. Gollamudi, K. Schupak et al., Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.2, pp.319-344, 2000.
DOI : 10.1016/S0360-3016(00)00448-X

T. Merchant and B. Mccormick, Prone position breast irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.30, issue.1, pp.197-203, 1994.
DOI : 10.1016/0360-3016(94)90535-5

A. Fourquet, F. Campana, J. Rosenwald, and J. Vilcoq, Breast irradiation in the lateral decubitus position: technique of the Institut Curie, Radiotherapy and Oncology, vol.22, issue.4, pp.261-266, 1991.
DOI : 10.1016/0167-8140(91)90160-I

F. Campana, Y. Kirova, J. Rosenwald, R. Dendale, J. Vilcoq et al., Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.5, pp.1348-54, 2005.
DOI : 10.1016/j.ijrobp.2004.08.051

Y. Kirova, T. Hijal, F. Campana, N. Fournier-bidoz, A. Stilhart et al., Whole breast radiotherapy in the lateral decubitus position: A dosimetric and clinical solution to decrease the doses to the organs at risk (OAR), Radiotherapy and Oncology, vol.110, issue.3, pp.477-81, 2014.
DOI : 10.1016/j.radonc.2013.10.038

F. Campana, Y. Kirova, J. Rosenwald, R. Dendale, J. Vilcoq et al., Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.5, pp.1348-54, 2005.
DOI : 10.1016/j.ijrobp.2004.08.051

Y. Kirova, F. Campana, A. Savignoni, F. Laki, M. Muresan et al., Breast-Conserving Treatment in the Elderly: Long-Term Results of Adjuvant Hypofractionated and Normofractionated Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.75, issue.1, pp.76-81, 2009.
DOI : 10.1016/j.ijrobp.2008.11.005

J. Owen, A. Ashton, J. Bliss, J. Homewood, C. Harper et al., Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial, The Lancet Oncology, vol.7, issue.6, 2006.
DOI : 10.1016/S1470-2045(06)70699-4

T. Whelan, J. Pignol, M. Levine, J. Julian, R. Mackenzie et al., Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer, New England Journal of Medicine, vol.362, issue.6, pp.513-533, 2010.
DOI : 10.1056/NEJMoa0906260

S. Trialists-'group, S. Bentzen, R. Agrawal, E. Aird, J. Barrett et al., The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet Oncol, vol.9, issue.4, pp.331-372, 2008.

S. Trialists-'group, S. Bentzen, R. Agrawal, E. Aird, J. Barrett et al., The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet Lond Engl, vol.371, issue.9618, pp.1098-107, 2008.

J. Haviland, J. Owen, J. Dewar, R. Agrawal, J. Barrett et al., The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials, The Lancet Oncology, vol.14, issue.11, pp.1086-94, 2013.
DOI : 10.1016/S1470-2045(13)70386-3

Y. Kirova, F. Campana, A. Savignoni, F. Laki, M. Muresan et al., Breast-Conserving Treatment in the Elderly: Long-Term Results of Adjuvant Hypofractionated and Normofractionated Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.75, issue.1, pp.76-81, 2009.
DOI : 10.1016/j.ijrobp.2008.11.005

C. Chargari, Y. Kirova, F. Laki, A. Savignoni, T. Dorval et al., The impact of the loco-regional treatment in elderly breast cancer patients: Hypo-fractionated exclusive radiotherapy, single institution long-term results, The Breast, vol.19, issue.5, pp.413-419, 2010.
DOI : 10.1016/j.breast.2010.04.004

T. Lingos, A. Recht, F. Vicini, A. Abner, B. Silver et al., Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.2, pp.355-60, 1991.
DOI : 10.1016/0360-3016(91)90782-Y

Y. Kirova, Recent advances in breast cancer radiotherapy: Evolution or revolution, or how to decrease cardiac toxicity?, World Journal of Radiology, vol.2, issue.3, pp.103-111, 2010.
DOI : 10.4329/wjr.v2.i3.103

J. Veinot and W. Edwards, Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases, Human Pathology, vol.27, issue.8, pp.766-73, 1996.
DOI : 10.1016/S0046-8177(96)90447-5

S. Darby, D. Cutter, M. Boerma, L. Constine, L. Fajardo et al., Radiation-Related Heart Disease: Current Knowledge and Future Prospects, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.656-65, 2010.
DOI : 10.1016/j.ijrobp.2009.09.064

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910096

L. Fajardo and J. Stewart, Pathogenesis of radiation-induced myocardial fibrosis, Lab Investig J Tech Methods Pathol, vol.29, issue.2, pp.244-57, 1973.

M. Hooning, B. Aleman, M. Hauptmann, M. Baaijens, J. Klijn et al., Roles of Radiotherapy and Chemotherapy in the Development of Contralateral Breast Cancer, Journal of Clinical Oncology, vol.26, issue.34
DOI : 10.1200/JCO.2007.16.0192

C. Correa, H. Litt, W. Hwang, V. Ferrari, L. Solin et al., Coronary Artery Findings After Left-Sided Compared With Right-Sided Radiation Treatment for Early-Stage Breast Cancer, Journal of Clinical Oncology, vol.25, issue.21, pp.3031-3038, 2007.
DOI : 10.1200/JCO.2006.08.6595

J. Cuzick, H. Stewart, R. Peto, B. Fisher, S. Kaae et al., Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer, Cancer Treat Rep, vol.71, issue.1, pp.7-14, 1987.

E. Harris, C. Correa, W. Hwang, J. Liao, H. Litt et al., Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation Treatment, Journal of Clinical Oncology, vol.24, issue.25, pp.4100-4106, 2006.
DOI : 10.1200/JCO.2005.05.1037

S. Giordano, Y. Kuo, J. Freeman, T. Buchholz, G. Hortobagyi et al., Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer, JNCI Journal of the National Cancer Institute, vol.97, issue.6, pp.419-443, 2005.
DOI : 10.1093/jnci/dji067

L. Paszat, W. Mackillop, P. Groome, C. Boyd, K. Schulze et al., Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries., Journal of Clinical Oncology, vol.16, issue.8, 1998.
DOI : 10.1200/JCO.1998.16.8.2625

S. Darby, P. Mcgale, C. Taylor, and R. Peto, Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300???000 women in US SEER cancer registries, The Lancet Oncology, vol.6, issue.8, pp.557-65, 2005.
DOI : 10.1016/S1470-2045(05)70251-5

C. Glanzmann, P. Huguenin, U. Lütolf, R. Maire, J. R. Gumppenberg et al., Cardiac lesions after mediastinal irradiation for Hodgkin's disease, Radiotherapy and Oncology, vol.30, issue.1, pp.43-54, 1994.
DOI : 10.1016/0167-8140(94)90008-6

J. Gligorov, P. Debourdeau, O. Arsovski, and J. Lotz, Cardiac prevention: the oncologic point of view], Bull Cancer, vol.91, pp.192-200, 2004.

M. Campone, E. Bourbouloux, and P. Fumoleau, Cardiac dysfunction induced by trastuzumab]. Bull Cancer (Paris), pp.166-73, 2004.

S. Darby, M. Ewertz, P. Mcgale, A. Bennet, U. Blom-goldman et al., Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer, New England Journal of Medicine, vol.368, issue.11, pp.987-98, 2013.
DOI : 10.1056/NEJMoa1209825

S. Fuller, J. Haybittle, R. Smith, and H. Dobbs, Cardiac doses in post-operative breast irradiation, Radiotherapy and Oncology, vol.25, issue.1, pp.19-24, 1992.
DOI : 10.1016/0167-8140(92)90190-6

G. Gyenes, G. Gagliardi, I. Lax, T. Fornander, and L. Rutqvist, Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy., Journal of Clinical Oncology, vol.15, issue.4, pp.1348-53, 1997.
DOI : 10.1200/JCO.1997.15.4.1348

M. Adams, P. Hardenbergh, L. Constine, and S. Lipshultz, Radiation-associated cardiovascular disease, Critical Reviews in Oncology/Hematology, vol.45, issue.1, pp.55-75, 2003.
DOI : 10.1016/S1040-8428(01)00227-X

G. Gagliardi, L. Constine, V. Moiseenko, C. Correa, L. Pierce et al., Radiation Dose???Volume Effects in the Heart, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.3, pp.77-85, 2010.
DOI : 10.1016/j.ijrobp.2009.04.093

H. Greenberg and S. Jacobs, Incidence of radiation fibrosis after use of a standardized technique of radiotherapy for breast cancer, Cancer, vol.34, issue.9, pp.1289-92, 1966.
DOI : 10.1002/1097-0142(196609)19:9<1289::AID-CNCR2820190916>3.0.CO;2-7

I. Adamson and D. Bowden, Endothelial injury and repair in radiation-induced pulmonary fibrosis, Am J Pathol, vol.112, issue.2, pp.224-254, 1983.

K. Trott, T. Herrmann, and M. Kasper, Target cells in radiation pneumopathy, International Journal of Radiation Oncology*Biology*Physics, vol.58, issue.2, pp.463-472, 2004.
DOI : 10.1016/j.ijrobp.2003.09.045

S. Mcdonald, P. Rubin, T. Phillips, and L. Marks, Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.5, pp.1187-203, 1995.
DOI : 10.1016/0360-3016(94)00429-O

W. Ross, The Radiotherapeutic and Radiological Aspects of Radiation Fibrosis of the Lungs, Thorax, vol.11, issue.3, pp.241-249, 1956.
DOI : 10.1136/thx.11.3.241

G. Wynn, P. Bentley, R. Liebmann, and C. Fletcher, Mammary Parenchymal Angiosarcoma after Breast-Conserving Treatment for Invasive High-Grade Ductal Carcinoma, The Breast Journal, vol.41, issue.6, pp.558-567, 2004.
DOI : 10.1016/0360-3016(95)93157-3

M. Hernando, L. Marks, G. Bentel, S. Zhou, D. Hollis et al., Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.3, pp.650-659, 2001.
DOI : 10.1016/S0360-3016(01)01685-6

M. Graham, J. Purdy, B. Emami, W. Harms, W. Bosch et al., Clinical dose???volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC), International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.2, pp.323-332, 1999.
DOI : 10.1016/S0360-3016(99)00183-2

D. Pierce and D. Preston, Radiation-Related Cancer Risks at Low Doses among Atomic Bomb Survivors, Radiation Research, vol.154, issue.2, pp.178-86, 2000.
DOI : 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.328.7893

E. Cardis, M. Vrijheid, M. Blettner, E. Gilbert, M. Hakama et al., Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries, BMJ, vol.331, issue.7508, 2005.
DOI : 10.1136/bmj.38499.599861.E0

E. Cardis and M. Hatch, The Chernobyl Accident ??? An Epidemiological Perspective, Clinical Oncology, vol.23, issue.4, pp.251-60, 2011.
DOI : 10.1016/j.clon.2011.01.510

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107017

J. Maddams, D. Parkin, and S. Darby, The cancer burden in the United Kingdom in 2007 due to radiotherapy, International Journal of Cancer, vol.76, issue.12, pp.2885-93, 2011.
DOI : 10.1002/ijc.26240

K. Thijssens, R. Van-ginkel, A. Suurmeijer, E. Pras, W. Van-der-graaf et al., Radiation-Induced Sarcoma: A Challenge for the Surgeon, Annals of Surgical Oncology, vol.184, issue.Suppl 1, 2005.
DOI : 10.1245/ASO.2005.03.041

S. Neuhaus, N. Pinnock, V. Giblin, C. Fisher, K. Thway et al., Treatment and outcome of radiation-induced soft-tissue sarcomas at a specialist institution, European Journal of Surgical Oncology (EJSO), vol.35, issue.6, pp.654-663, 2009.
DOI : 10.1016/j.ejso.2008.11.008

Y. Kirova, J. Vilcoq, B. Asselain, X. Sastre-garau, and A. Fourquet, Radiation-induced sarcomas after radiotherapy for breast carcinoma, Cancer, vol.28, issue.4, pp.856-63, 2005.
DOI : 10.1002/cncr.21223

C. Mery, S. George, M. Bertagnolli, and C. Raut, Secondary sarcomas after radiotherapy for breast cancer, Cancer, vol.48, issue.18, pp.4055-63, 2009.
DOI : 10.1002/cncr.24462

E. Ibrahim, G. Kazkaz, K. Abouelkhair, M. Mansour, T. Fayea et al., Increased Risk of Second Lung Cancer in Hodgkin???s Lymphoma Survivors: A Meta-analysis, Lung, vol.80, issue.1, pp.117-151, 2013.
DOI : 10.1007/s00408-012-9418-4

F. Van-leeuwen, W. Klokman, A. Hagenbeek, R. Noyon, A. Van-den-belt-dusebout et al., Second cancer risk following Hodgkin's disease: a 20-year follow-up study., Journal of Clinical Oncology, vol.12, issue.2, pp.312-337, 1994.
DOI : 10.1200/JCO.1994.12.2.312

C. Metayer, C. Lynch, E. Clarke, B. Glimelius, H. Storm et al., Second Cancers Among Long-Term Survivors of Hodgkin???s Disease Diagnosed in Childhood and Adolescence, Journal of Clinical Oncology, vol.18, issue.12, pp.2435-2478, 2000.
DOI : 10.1200/JCO.2000.18.12.2435

Y. Kirova, L. Gambotti, Y. De-rycke, J. Vilcoq, B. Asselain et al., Risk of Second Malignancies After Adjuvant Radiotherapy for Breast Cancer: A Large-Scale, Single-Institution Review, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.2, pp.359-63, 2007.
DOI : 10.1016/j.ijrobp.2006.12.011

B. Offersen, L. Boersma, C. Kirkove, S. Hol, M. Aznar et al., ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1, Radiotherapy and Oncology, vol.118, issue.1, 2016.
DOI : 10.1016/j.radonc.2015.12.027

Y. Kirova, C. Pena, P. Hijal, T. Fournier-bidoz, N. Laki et al., Improving the Definition of Tumor Bed Boost With the Use of Surgical Clips and Image Registration in Breast Cancer Patients, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.5, pp.1352-1357, 2010.
DOI : 10.1016/j.ijrobp.2009.10.049

F. Mornex, J. Pavy, J. Denekamp, and M. Bolla, Syst??me d'??valuation des effets tardifs des radiations sur les tissus normaux: l'??chelle SOMA-LENT, Cancer/Radioth??rapie, vol.1, issue.6, pp.622-68, 1997.
DOI : 10.1016/S1278-3218(97)82941-1

S. Darby, P. Mcgale, R. Peto, F. Granath, P. Hall et al., Research pointers: Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women, BMJ, vol.326, issue.7383, pp.256-263, 2003.
DOI : 10.1136/bmj.326.7383.256

J. Vaidya, D. Joseph, J. Tobias, M. Bulsara, F. Wenz et al., Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial, The Lancet, vol.376, issue.9735, pp.91-102, 2010.
DOI : 10.1016/S0140-6736(10)60837-9

URL : http://mediatum.ub.tum.de/doc/1074158/document.pdf

C. Taylor, A. Nisbet, P. Mcgale, U. Goldman, S. Darby et al., Cardiac doses from Swedish breast cancer radiotherapy since the 1950s, Radiotherapy and Oncology, vol.90, issue.1, pp.127-162, 2009.
DOI : 10.1016/j.radonc.2008.09.029

P. Inskip, M. Stovall, and J. Flannery, Lung Cancer Risk and Radiation Dose Among Women Treated for Breast Cancer, JNCI Journal of the National Cancer Institute, vol.86, issue.13, pp.983-991, 1994.
DOI : 10.1093/jnci/86.13.983

F. Kong, E. Klein, J. Bradley, D. Mansur, M. Taylor et al., The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation, International Journal of Radiation Oncology*Biology*Physics, vol.54, issue.3, pp.963-71, 2002.
DOI : 10.1016/S0360-3016(02)03741-0

P. Lind, B. Wennberg, G. Gagliardi, and T. Fornander, Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose, Breast Cancer Research and Treatment, vol.16, issue.14, pp.199-210, 2001.
DOI : 10.1023/A:1012292019599

T. Hijal, N. Fournier-bidoz, P. Castro-pena, Y. Kirova, S. Zefkili et al., Simultaneous integrated boost in breast conserving treatment of breast cancer: A dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy, Radiotherapy and Oncology, vol.94, issue.3, pp.300-306, 2010.
DOI : 10.1016/j.radonc.2009.12.043

J. Caudrelier, S. Morgan, L. Montgomery, M. Lacelle, B. Nyiri et al., Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluation, Radiotherapy and Oncology, vol.90, issue.1, pp.99-105, 2009.
DOI : 10.1016/j.radonc.2008.09.028

P. Ciammella, A. Podgornii, M. Galeandro, R. Micera, D. Ramundo et al., Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors, Radiation Oncology, vol.9, issue.1, p.97, 2014.
DOI : 10.1016/j.radonc.2012.06.002

URL : http://doi.org/10.1186/1748-717x-9-97

A. Abner, A. Recht, F. Vicini, B. Silver, D. Hayes et al., Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.2, pp.331-339, 1991.
DOI : 10.1016/0360-3016(91)90779-4

G. Beadle, S. Come, I. Henderson, B. Silver, S. Hellman et al., The effect of adjuvant chemotherapy on the cosmetic results after primary radiation treatment for early stage breast cancer, International Journal of Radiation Oncology*Biology*Physics, vol.10, issue.11, pp.2131-2138, 1984.
DOI : 10.1016/0360-3016(84)90213-X

U. Hille-betz, B. Vaske, M. Bremer, P. Soergel, S. Kundu et al., Sp??tnebenwirkungen der Bestrahlung, kosmetisches Ergebnis und Schmerzen bei Brustkrebspatientinnen nach brusterhaltender Chirurgie und dreidimensionaler konformaler Strahlentherapie, Strahlentherapie und Onkologie, vol.13, issue.1
DOI : 10.1007/s00066-015-0899-y

L. Keller, D. Sopka, T. Li, T. Klayton, J. Li et al., Five-year Results of Whole Breast Intensity Modulated Radiation Therapy for the Treatment of Early Stage Breast Cancer: The Fox Chase Cancer Center Experience, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.4, pp.881-888, 2012.
DOI : 10.1016/j.ijrobp.2012.01.069

K. Gokula, A. Earnest, and L. Wong, Meta-analysis of incidence of early lung toxicity in 3-dimensional conformal irradiation of breast carcinomas, Radiation Oncology, vol.8, issue.1, p.268, 2013.
DOI : 10.1200/JCO.2003.06.064

M. Krengli, M. Sacco, G. Loi, L. Masini, D. Ferrante et al., Pulmonary Changes After Radiotherapy for Conservative Treatment of Breast Cancer: A Prospective Study, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.5, pp.1460-1467, 2008.
DOI : 10.1016/j.ijrobp.2007.08.050

A. Kubo, K. Osaki, T. Kawanaka, S. Furutani, H. Ikushima et al., Risk factors for radiation pneumonitis caused by whole breast irradiation following breast-conserving surgery, The Journal of Medical Investigation, vol.56, issue.3,4, pp.3-499, 2009.
DOI : 10.2152/jmi.56.99

N. Boekel, M. Schaapveld, J. Gietema, N. Russell, P. Poortmans et al., Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer??Survivors, International Journal of Radiation Oncology*Biology*Physics, vol.94, issue.5, pp.1061-72, 2016.
DOI : 10.1016/j.ijrobp.2015.11.040

A. Fiorentino, R. Mazzola, F. Ricchetti, G. Levra, N. Fersino et al., Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity, Cancer/Radioth??rapie, vol.19, issue.5, pp.289-94, 2015.
DOI : 10.1016/j.canrad.2015.02.013

C. Polgár, J. Fodor, Z. Orosz, T. Major, Z. Takácsi-nagy et al., Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial, Strahlenther Onkol Organ Dtsch Röntgenges Al, vol.178, issue.11, pp.615-638, 2002.

M. Taylor, C. Perez, K. Halverson, R. Kuske, G. Philpott et al., Factors influencing cosmetic results after conservation therapy for breast cancer, International Journal of Radiation Oncology*Biology*Physics, vol.31, issue.4, pp.753-64, 1995.
DOI : 10.1016/0360-3016(94)00480-3

I. Olivotto, M. Rose, R. Osteen, S. Love, B. Cady et al., Late cosmetic outcome after conservative surgery and radiotherapy: Analysis of causes of cosmetic failure, International Journal of Radiation Oncology*Biology*Physics, vol.17, issue.4, pp.747-53, 1989.
DOI : 10.1016/0360-3016(89)90061-8

S. Galland-girodet, I. Pashtan, S. Macdonald, M. Ancukiewicz, A. Hirsch et al., Long-term Cosmetic Outcomes and Toxicities of Proton Beam Therapy Compared With Photon-Based 3-Dimensional Conformal Accelerated Partial-Breast Irradiation: A Phase 1 Trial, International Journal of Radiation Oncology*Biology*Physics, vol.90, issue.3, pp.493-500, 2014.
DOI : 10.1016/j.ijrobp.2014.04.008

A. Liss, M. Ben-david, R. Jagsi, J. Hayman, K. Griffith et al., Decline of Cosmetic Outcomes Following Accelerated Partial Breast Irradiation Using Intensity Modulated Radiation Therapy: Results of a Single-Institution Prospective Clinical Trial, International Journal of Radiation Oncology*Biology*Physics, vol.89, issue.1, pp.96-102, 2014.
DOI : 10.1016/j.ijrobp.2014.01.005

M. Guenzi, F. Giannelli, D. Bosetti, G. Blandino, M. Milanese et al., Two different hypofractionated breast radiotherapy schedules for 113 patients with ductal carcinoma in situ: preliminary results, Anticancer Res, vol.33, issue.8, pp.3503-3510, 2013.

I. Linares, M. Tovar, M. Zurita, R. Guerrero, M. Expósito et al., Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity. Clin Breast Cancer, 2016.
DOI : 10.1016/j.clbc.2015.09.012

C. Herbert, A. Nichol, I. Olivotto, L. Weir, R. Woods et al., The Impact of Hypofractionated Whole Breast Radiotherapy on Local Relapse in Patients With Grade 3 Early Breast Cancer: A Population-Based Cohort Study, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.5, pp.2086-92, 2012.
DOI : 10.1016/j.ijrobp.2011.01.055